Sergio L. Almeida
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: November 29, 2022
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
Journal: Journal of molecular cell biology
Published: June 18, 2021
Infection of human lymphomononuclear cells by SARS-CoV-2.
Journal: bioRxiv : the preprint server for biology
Published: May 20, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Journal: RMD open
Published: September 18, 2020
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
Journal: The Journal of experimental medicine
Published: June 06, 2020
A single episode of high intensity sound inhibits long-term potentiation in the hippocampus of rats.
A single episode of high intensity sound inhibits long-term potentiation in the hippocampus of rats.
Journal: Scientific reports
Published: May 18, 2017
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 13, 2015
CCR2 Expression in Neutrophils Plays a Critical Role in Their Migration Into the Joints in Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 13, 2014
Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 12, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026